+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial



Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial



Journal of Drugs in Dermatology 5(7): 646-650



The first gel formulation of ketoconazole has been tested in 2-week treatment courses. To evaluate the efficacy and safety of a new, once-daily, 2-week ketoconazole 2% gel treatment in moderate to severe seborrheic dermatitis. Four hundred fifty-nine subjects with moderate to severe seborrheic dermatitis were randomized to receive ketoconazole 2% gel or vehicle gel once daily for 14 days. The primary efficacy was the proportion of successfully treated subjects at day 28 (cleared and almost cleared). A significantly greater percentage of subjects were successfully treated with ketoconazole 2% gel compared with vehicle (25.3% vs. 13.9%, P = .0014). Ketoconazole 2% gel improved erythema, scaling (P = .0022 vs. vehicle), and pruritus. Mean overall symptom severity was reduced by 53% and 39% with ketoconazole gel and vehicle, respectively. Adverse events were few, generally mild or moderate, and similar between treatment groups. Once-daily ketoconazole 2% gel is an effective,well-tolerated, convenient, and cosmetically acceptable treatment for moderate to severe seborrheic dermatitis.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048918633

Download citation: RISBibTeXText

PMID: 16865870


Related references

Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study. Journal of Drugs in Dermatology 12(1): E1-E6, 2013

Efficacy and safety of a low-molecular weight hyaluronic Acid topical gel in the treatment of facial seborrheic dermatitis. Journal of Clinical and Aesthetic Dermatology 5(10): 20-23, 2012

Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy. American Journal of Clinical Dermatology 10(2): 103-118, 2009

An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face. Clinics in Dermatology 27(6 Suppl): S48-S53, 2010

Efficacy and safety of a low molecular weight hyaluronic Acid topical gel in the treatment of facial seborrheic dermatitis final report. Journal of Clinical and Aesthetic Dermatology 7(5): 15-18, 2014

Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial. Archives of Dermatology 146(4): 446-449, 2010

An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. Journal of Dermatological Treatment 20(1): 4-9, 2008

Chronic use of 2 percent ketoconazole shampoo in patients with seborrheic dermatitis and dandruff ketoconazole plasma levels and safety. Current Therapeutic Research 43(1): 43-47, 1988

Topical Application of 5-Fluorouracil Associated with Distant Seborrheic Dermatitis-like Eruption: Case Report and Review of Seborrheic Dermatitis Cutaneous Reactions after Systemic or Topical Treatment with 5-Fluorouracil. Dermatology and Therapy 8(3): 495-501, 2018

Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis, and seborrheic dermatitis. Cutis 27(6): 670-671, 1981

Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. International Journal of Dermatology 43 Suppl 1: 17-20, 2004

Clinical evaluation of the efficacy of a topical preparation containing pyridoxine and cystine in seborrheic dermatitis and in seborrheic condition of the face. Giornale Italiano di Dermatologia E Venereologia 121(4): Li-Liii, 1986

A Phase II Trial to Assess the Safety and Efficacy of a Topical Repair Cream Containing Skin-identical Ceramide Complex in Patients with Contact Dermatitis. Journal of Clinical and Aesthetic Dermatology 11(11): 40-44, 2018

The safety of ketoconazole shampoo for infantile seborrheic dermatitis. Pediatric Dermatology 15(5): 406-407, 1998

Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial. British Journal of Dermatology 2019, 2019